Nutrition and health

Objectives:
Probiotic supplementation in early life may be effective in preventing atopic dermatitis (AD); however, results regarding efficacy have been controversial. Therefore, this meta-analysis (systematic review) has been conducted.

Does probiotic supplementation in early life prevent atopic dermatitis in infants and children?

Study design:
This review article included 28 RCTs.

Results and conclusions:
The investigators found compared with controls, probiotic supplementation of mother was associated with a significantly reduced risk of 31% for atopic dermatitis in infants and children [OR = 0.69, 95% CI = 0.58-0.82, p  0.0001].

The investigators found compared with controls, the use of probiotics of mother during both the prenatal and the postnatal period significantly reduced the incidence of atopic dermatitis in infants and children with 33% [OR = 0.67, 95% CI = 0.54-0.82].
However, analysis of studies of probiotics given prenatally only or postnatally only did not reach statistical significance.

The investigators concluded that probiotic supplementation of mother during both the prenatal and the postnatal period reduces the incidence of atopic dermatitis in infants and children. These findings suggest that starting probiotic treatment during gestation and continuing through the first 6 months of the infant's life may be of benefit in the prevention of atopic dermatitis.

Original title:
Probiotic Supplementation for Prevention of Atopic Dermatitis in Infants and Children: A Systematic Review and Meta-analysis by Li L, Han Z, […], He C.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30465329

Additional information of El Mondo:
Find more information/studies on protbiotics and pregnancy right here.
 

Objectives:
Inositol (ISL) embraces a family of simple carbohydrates with insulin-sensitizing properties, whose most common isoforms are Myo-inositol (MYO) and D-chiro inositol (DCI). Therefore, this meta-analysis (systematic review) has been conducted.

Does inositol supplementation reduce gestational diabetes (GDM)?

Study design:
This review article included 5 RCTs with a total of  965 participants.
The primary outcome was the preventive effect on gestational diabetes, defined as the rate of gestational diabetes in women without a prior diagnosis of gestational diabetes.
Pooled results were expressed as odds ratio (OR) with a 95% confidence interval (95% CI).
No adverse effects were reported for inositol supplementation.

Results and conclusions:
The investigators found inositol supplementation significantly reduced risk of gestational diabetes with 51% [OR = 0.49, p = 0.01]. However, this reduced risk was only significant in patients receiving 2g inositol twice daily.

The investigators found inositol supplementation significantly reduced risk of preterm delivery with 65% [OR = 0.35, 95% CI = 0.17-0.74, p = 0.006]. However, this reduced risk was only significant in patients receiving 2g inositol twice daily.

The investigators concluded double administration of inositol 2g per day reduces gestational diabetes rate and preterm delivery rate. Therefore, inositol supplementation may represent a novel strategy for gestational diabetes prevention.

Original title:
Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials by Vitagliano A, Saccone G, […], Berghella V.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30564926

Additional information of El Mondo:
Find more information/studies on inositol and pregnancy right here.
 

Objectives:
Infertility, which affects ∼15% of the world's population, is a global public health issue recognized by the WHO. Therefore, it is of major clinical and public health importance to investigate whether modifiable lifestyle factors,such as stress, drug use, smoking, alcohol intake and diet may influence human fertility. Therefore, this meta-analysis (systematic review) has been conducted.

What is the effect of supplementation of nutrients on sperm quality parameters?

Study design:
This review article included 28 articles (RCTs) for qualitative analysis and 15 for quantitative meta-analysis.

Results and conclusions:
The investigators found total sperm concentrations were significantly increased by:
-selenium [MD = 3.91 × 106 spz/mL, 95% CI = 3.08 to 4.73 spz/mL];
-zinc [MD = 1.48 × 106 spz/mL, 95% CI = 0.69 to 2.27 spz/mL];
-omega 3 fatty acids [MD = 10.98 × 106 spz/mL, 95% CI = 10.25 to 11.72 spz/mL] and
-coenzyme Q10 [MD = 5.93 × 106 spz/mL, 95% CI = 5.36 to 6.51 spz/mL].

The investigators found sperm counts were significantly increased by:
-omega 3 fatty acids [MD = 18.70 × 106 spz/mL, 95% CI = 16.89 to 20.51 spz/mL] and
-coenzyme Q10 [MD = 10.15 × 106 spz/mL, 95% CI = 8.34 to 11.97 spz/mL].

The investigators found sperm total motility was significantly increased by:
-selenium [MD = 3.30%, 95% CI = 2.95% to 3.65%];
-zinc [MD = 7.03%, 95% CI = 6.03% to 8.03%];
-omega 3 fatty acids [MD = 7.55%, 95% CI = 7.09% to 8.01%];
-coenzyme Q10 [MD = 5.30%, 95% CI = 4.98% to 5.62%] and
-carnitines [MD = 7.84%, 95% CI = 6.54% to 9.13%].

The investigators found sperm progressive motility significantly increased by supplementation with carnitines [MD = 7.45%, 95% CI = 6.24% to 8.67%].

The investigators found sperm morphology was significantly enhanced by:
-selenium [MD = 1.87%, 95% CI = 1.50% to 2.24%];
-omega 3 fatty acid [MD = 0.91%, 95% CI = 0.69% to 1.13%];
-coenzyme Q10 [MD = 1.06%, 95% CI = 0.72% to 1.41%] and
-carnitine [MD = 4.91%, 95% CI = 3.68% to 6.15%].

The investigators concluded evidence from RCTs shows that some dietary supplements beneficially modulate sperm quality parameters and affect male fertility. However, results must be cautiously interpreted due to the limited sample size of the meta-analyzed studies and the considerable observed interstudy heterogeneity.

Original title:
The Effect of Nutrients and Dietary Supplements on Sperm Quality Parameters: A Systematic Review and Meta-Analysis of Randomized Clinical Trials by Salas-Huetos A, Rosique-Esteban N, […], Salas-Salvadó J.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30462179

Additional information of El Mondo:
Find more information/studies on mineral, antioxidants and pregnancy right here.

 

Objectives:
Is there an association between dietary factors and the risk of gout and hyperuricemia?
 
Study design:
This review article included 10 prospective cohort studies (the follow-up duration ranged from 6 years to 26 year) and 9 cross-sectional studies.

Based on the Newcastle-Ottawa Scale (NOS), the quality assessment of included studies yielded a mean NOS score of 7.1, suggesting the presence of high methodologic quality.

Results and conclusions:
The investigators found in meta-analysis that the risk of getting gout significantly increased with:
29% [OR = 1.29, 95% CI = 1.16-1.44] for dietary red meat intake;
31% [OR = 1.31, 95% CI = 1.01-1.68] for dietary seafoods intake;
158% [OR = 2.58, 95% CI = 1.81-3.66] for dietary alcohol intake;
114% [OR = 2.14, 95% CI = 1.65-2.78] for dietary fructose intake.

The investigators found in meta-analysis that the risk of getting gout significantly decreased with:
44% [OR = 0.56, 95% CI = 0.44-0.70] for dietary dairy products intake;
15% [OR = 0.85, 95% CI = 0.76-0.96] for dietary soy foods intake;
14% [OR = 0.86, 95% CI = 0.75-0.98] for dietary high-purine vegetables intake;
53% [OR = 0.47, 95% CI = 0.37-0.59] for dietary coffee intake.

The investigators found in meta-analysis that the risk of getting hyperuricemia (an excess of uric acid in the blood) significantly increased with:
24% [OR = 1.24, 95% CI = 1.04-1.48] for dietary red meat intake;
47% [OR = 1.47, 95% CI = 1.16-1.86] for dietary seafoods intake;
106% [OR = 2.06, 95% CI = 1.60-2.67] for dietary alcohol intake;
85% [OR = 1.85, 95% CI = 1.66-2.07] for dietary fructose intake.

The investigators found in meta-analysis that the risk of getting hyperuricemia (an excess of uric acid in the blood) significantly decreased with:
50% [OR = 0.50, 95% CI = 0.37-0.66] for dietary dairy products intake;
30% [OR = 0.70, 95% CI = 0.56-0.88] for dietary soy foods intake.

The investigators found in meta-analysis that the risk of getting hyperuricemia (an excess of uric acid in the blood) non-significantly increase with:
10% [OR = 1.10, 95% CI = 0.88-1.39] for dietary high-purine vegetables intake.

The investigators found in meta-analysis that the risk of getting hyperuricemia (an excess of uric acid in the blood) non-significantly decreased with 24% [OR = 0.76, 95% CI = 0.55-1.06] for dietary coffee intake in men.
Non-significantly because OR of 1 was found in the 95% CI of 0.55 to 1.06. OR of 1 means no risk/association.

The investigators found in meta-analysis that the risk of getting hyperuricemia (an excess of uric acid in the blood) significantly increased with 58% [OR = 1.58, 95% CI = 1.16-2.16] for dietary coffee intake in women.
Significant because OR of 1 was not found in the 95% CI of 1.16 to 2.16. OR of 1 means no risk/association.

The investigators concluded that the risk of hyperuricemia and gout is positively correlated with the dietary intake of red meat, seafoods, alcohol or fructose and negatively with dairy products or soy foods. High-purine vegetables show no association with hyperuricemia, but negative association with gout. Coffee intake is negatively associated with gout risk, whereas it is positively associated with hyperuricemia risk in women.

Original title:
Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review by Li R, Yu K and Li C.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30485934

Additional information of El Mondo:
Find more information/studies on food groups and chronic diseases right here.

Objectives:
Postherpetic neuralgia (PHN) is the most distressful complication of herpes zoster. Postherpetic neuralgia results in an impaired quality of life and higher healthcare utilization. Vitamin B12 has been proven to be effective in pain relief for various conditions. Therefore, this review article has been conducted.

Do postherpetic neuralgia patients benefit from vitamin B12 supplementation?

Study design:
This review article included 4 RCTs (published between 2013 and 2016) including 383 participants.

Results and conclusions:
The investigators found compared with the placebo group, the vitamin B12 group exhibited a significant decrease in the Numeric Rating Scale score, with a mean difference of -4.01 [95% CI = -4.70 to -3.33].

The investigators found compared with the placebo group, vitamin B12 administration improved the quality of life of postherpetic neuralgia patients with moderate quality evidence and significantly decreased the number of patients using analgesics.

The investigators concluded that vitamin B12 appears to be an attractive complementary therapy for postherpetic neuralgia patients. However, further investigation is needed before conclusive recommendations can be made.

Original title:
Vitamin B12 for herpetic neuralgia: A meta-analysis of randomised controlled trials by Wang JY, Wu YH, [...], Lu PH.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30477853

Additional information of El Mondo:
Find more information/studies on vitamin B12 and chronic diseases right here.

Postherpetic neuralgia (PHN) is a nerve pain (neuralgia) that persists after a shingles rash has cleared. Postherpetic neuralgia is caused by the chickenpox (varicella-zoster) virus.
 

Objectives:
The timing of the introduction of egg to an infant's diet is of current interest, as new evidence raises questions regarding the benefit of delaying egg introduction. Therefore, this meta-analysis (systematic review) has been conducted.

Does early introduction of egg into an infant’s diet reduce risk of egg allergy?

Study design:
This review article included 6 RCTs with a total of 3,032 participants.
The RCTs compared early (between 3 and 6 months of age) egg introduction to no early introduction. The primary outcome was the development of egg allergy.

Results and conclusions:
The investigators found compared early (between 3 and 6 months of age) egg introduction to no early introduction, early introduction of egg significantly reduced risk of egg allergy with 40% [RR = 0.60, 95% CI = 0.44-0.82, p = 0.002, I2 = 23%, low to moderate level of evidence].

The investigators found the absolute risk reduction for a population with an incidence of egg allergy was 9.3% or 37 fewer cases [95% CI = 17-52] per 1,000 people.

The investigators found consumption of 4,000 mg/week of egg protein had a greater preventive effect than a higher dose.

The investigators concluded that introduction of egg into an infant’s diet between 3 and 6 months of age reduces risk of egg allergy, particularly for 4,000 mg/week of egg protein. Furthermore, the nature and dose of egg protein exposure may play a role. These findings should be addressed in the context of primary studies.

Original title:
Early Introduction of Egg and the Development of Egg Allergy in Children: A Systematic Review and Meta-Analysis by Al-Saud B and Sigurdardóttir ST.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30184525

Additional information of El Mondo:
Find more information/studies on protein and pregnancy right here.
 

Objectives:
Does magnesium supplementation reduce C-reactive protein concentrations in humans?

Study design:
This review article included 8 RCTs (2004-2014) with 349 participants.

The mean age of participants ranged from 18 to 85 years.
The range of duration of the supplementation intervention across studies was from 8 h to 6.5 months.
The consumed range of magnesium dose in these studies was from 320 to 1500 mg/day. The baseline level (at the start of the study) of the CRP varied between the studies from 0.42 mg/dL as minimum to 9.4 mg/dL as maximum.

Results and conclusions:
The investigators found magnesium supplementation significantly reduced serum CRP levels [WMD = -1.33 mg/dL, 95% CI = -2.63 to -0.02, p 0.001, I2 = 29.1%, p 0.123] across all studies.
In leave-one-out sensitivity analyses, the pooled effect estimates remained similar across all studies for CRP levels [WMD = -1.33 mg/dL, 95% CI = -2.63 to -0.02].

The investigators found after adjustment of the effect size for potential publication bias using the “trim and fill” correction, no potentially missing studies were imputed in the funnel plot [WMD = -1.33 mg/dL, 95% CI = -2.63 to -0.02]. The “fail-safe N” test showed that 146 studies would be needed to bring the WMD down to a non-significant [p > 0.05] value.

The investigators found in random-effects meta-regression changes in serum CRP levels were independent of the dosage of magnesium [slope = -0.004, 95% CI = -0.03 to 0.02, p = 0.720, and duration [slope = -0.06, 95% CI = -0.37 to 0.24, p = 0.681] of supplementation.

The investigators found in 4 RCTs that subjects with a baseline CRP of ≥ 2 mg/dL had more significant reduction in the serum CRP level [WMD = -2.95 mg/dL, 95% CI = -3.35 to -2.25, p 0.001, I2 = 1.1%, p = 0.952] compared with subjects with a baseline CRP of 2 mg/dL [WMD = -0.23 mg/dL, 95% CI = -0.195 to -0.326, p 0.001, I2 = 1.3% p = 0.923].

The investigators found magnesium supplementation non-significantly reduced IL-6 levels [WMD = -0.16 pg/dL, 95% CI = -3.52 to 3.26, p = 0.236, I2 = 2.3%, p = 0.802] across all studies.

The investigators found magnesium supplementation significantly increased TNF-α levels [WMD = 1.97 pg/dL, 95% CI = 1.12 to 2.82, p = 0.043, I2 = 2.1%, p = 0.869] across all studies.

The investigators found magnesium supplementation non-significantly decreased fasting blood glucose (FBG) levels [WMD = -0.61 mg/dL, 95% CI = -2.72 to 1.48, p = 0.182, I2 = 6.1%, p = 0.742] across all studies.

The investigators found magnesium supplementation non-significantly decreased systolic blood pressure levels [WMD = -0.93 mmHg, 95% CI = -3.03 to 1.20, p = 0.293, I2 = 3.6%, p = 0.526] across all studies.

The investigators found magnesium supplementation non-significantly decreased diastolic blood pressure levels [WMD = -0.30 mmHg, 95% CI = -2.80 to 2.19, p = 0.639, I2 = 3.8%, p = 0.489] across all studies.

The investigators found magnesium supplementation non-significantly increased BMI levels [WMD = 0.27 kg/m², 95% CI = -0.59 to 1.15, p = 0.542, I2 = 2.0%, p = 0.906] across all studies.  

The investigators concluded that 320 to 1500 mg/day magnesium supplementation decreases serum CRP levels, especially with the baseline values ≥ 2 mg/dL. To provide more conclusive results and clarify the mechanistic pathways, RCTs with a larger sample size and a long-term follow-up period are warranted.

Original title:
Effect of magnesium supplements on serum C-reactive protein: a systematic review and meta-analysis by Mazidi M, Rezaie P and Banach M.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040119/

Additional information of El Mondo:
Find more information/studies on magnesium and chronic diseases right here.
 

Objectives:
Dietary salt reduction in the general population lowers blood pressure and cardiovascular risk. Despite being widely recommended, there is limited evidence as to whether this is applicable to individuals with end-stage renal disease (ESRD) receiving dialysis. Therefore, this review article has been conducted.

Study design:
This review article included 4 RCTs (91 participants), of which 3 were crossover trials and 1 was a parallel study.
Participants were 18 years and over; a reduction in salt intake of at least 1 g/day over 1 week and no concomitant interventions during the study.
The primary outcome was change in systolic and diastolic blood pressure.

Results and conclusions:
The investigators found dietary salt reduction was associated with an 8.4 mmHg [95% CI = 4.8-12.0, Ι2 = 0%] reduction in systolic blood pressure and a 4.4 mmHg [95% CI = 2.2-6.6, Ι2 = 0%] reduction in diastolic blood pressure.

The investigators concluded that a reduction in salt intake of at least 1 g/day over 1 week reduces blood pressure among individuals with end-stage renal disease (ESRD) receiving dialysis.

Original title:
The effect of dietary salt on blood pressure in individuals receiving chronic dialysis: a systematic review and meta-analysis of randomised controlled trials by Cole NI, Swift PA, […], Suckling RJ.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/30413764

Additional information of El Mondo:
Find more information/studies on lowering blood pressure, salt intake and chronic disease right here.
 

Objectives:
Low birth weight infant (LBWIs) are prone to mental and behavioural problems. As an important constituent of the brain and retina, long chain polyunsaturated fatty acids are essential for foetal infant mental and visual development. The effect of lactation supplemented with long chain polyunsaturated fatty acids (LCPUFA) on the improvement of intelligence in low birth weight children requires further validation. Therefore, this meta-analysis (systematic review) has been conducted.

Do long chain polyunsaturated fatty acids (LCPUFA or PUFA) supplements improve intelligence in low birth weight children?

Study design:
This review article included 10 studies with a total of 1,793 individuals, of which 908 cases in the intervention group (group with LCPUFA supplements) and 885 controls (group without LCPUFA supplements).

The mean birth weights in 8 studies were less than 1500g and those in 2 studies were more than 1500g. None of the included studies had infants with birth weight less than 750g.

LCPUFA supplements were DHA+AA, DHA+EPA+DPA or DHA+AA+EPA.

There was no evidence of publication bias.

Results and conclusions:
The investigators found that the long chain polyunsaturated fatty acids supplemented group did not have significantly higher mental development index (MDI) scores than the group without supplementation [SMD = 0.07, 95% CI = -0.05 to 0.19, I2 = 23.8%, p = 0.222].
Subgroup analysis showed that the long chain polyunsaturated fatty acids supplementation groups did not have significantly higher mental development index scores than the control groups.

The investigators found that the long chain polyunsaturated fatty acids supplemented group did not have significantly higher psychomotor development index (PDI) scores than the group without supplementation [SMD = -0.01, 95% CI = -0.23 to 0.21, I2 = 60.5%, p = 0.906].
Subgroup analysis showed that the long chain polyunsaturated fatty acids supplementation groups did not have significantly higher psychomotor development index scores than the control groups.

The investigators found that the long chain polyunsaturated fatty acids supplemented group did not have significantly higher full scale intelligence quotient (FSIQ) scores than the group without supplementation [SMD = 0.00, 95% CI = -0.14 to 0.14, I2 = 0.00%, p = 0.991].

The investigators found that the long chain polyunsaturated fatty acids supplemented group did not have significantly higher verbal intelligence quotient (VIQ) scores than the group without supplementation [SMD = 0.01, 95% CI = -0.15 to 0.12, I2 = 42.2%, p = 0.844].

The investigators found that the long chain polyunsaturated fatty acids supplemented group did not have significantly higher performance intelligence quotient (PIQ) scores than the group without supplementation [SMD = -0.01, 95% CI = -0.15 to 0.13, I2 = 0.00, p = 0.877].

The investigators concluded that long chain polyunsaturated fatty acids (LCPUFA or PUFA) supplements do not improve intelligence in low birth weight children. Therefore, whether long-chain polyunsaturated fatty acids supplements are beneficial for LBWIs has not been shown conclusively.

Original title:
The effect of long chain polyunsaturated fatty acid supplementation on intelligence in low birth weight infant during lactation: A meta-analysis by Song Y, Liu Y, […], Li D.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892917/

Additional information of El Mondo:
Find more information/studies on long chain polyunsaturated fatty acids and pregnancy right here.

 

Objectives:
The association between coffee consumption and the circulating level of adiponectin and leptin has been evaluated in several epidemiological studies with conflicting results. Therefore, this review article has been conducted.

Is there an association between coffee consumption and the circulating level of adiponectin and leptin in humans?

Study design:
This review article included 12 cross-sectional studies.

Results and conclusions:
The investigators found when compared the highest versus the lowest coffee intake category, coffee consumption was associated with a higher circulating adiponectin level [SMD = 0.11, 95% CI = 0.06 to 0.17, p 0.001].

The investigators found in subgroup analysis when compared the highest versus the lowest coffee intake category, coffee consumption was associated with a higher circulating adiponectin level in women [SMD = 0.11, 95% CI = 0.02 to 0.20, p = 0.01], but not in men [SMD = 0.03, 95% CI = -0.08 to 0.14, p = 0.59].

The investigators found when compared the highest versus the lowest coffee intake category, coffee consumption was associated with a lower circulating leptin level [SMD = -0.19, 95% CI = -0.28 to -0.10, p 0.001].

The investigators concluded that coffee consumption is associated with a higher circulating level of adiponectin in women and a lower circulating level of leptin. However, more well-designed prospective cohort studies and randomised controlled trials are needed to further elaborate the concerned issues.

Original title:
Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies by Zhang Y and Zhang DZ.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29513118

Additional information of El Mondo:
Find more information/studies on coffee consumption, diabetes and overweight right here.

Adiponectin is a unique adipokine, which is specifically and abundantly expressed in adipose tissues and improves insulin resistance. Having insulin resistance may increase the risk of type 2 diabetes and metabolic syndrome.

Objectives:
Inflammation is associated with an increased risk of a range of chronic diseases. A diet high in fruit and vegetables may help to reduce inflammation, as fruit and vegetables are rich sources of antioxidants and other biologically active substances, which may improve immune function. Therefore, this meta-analysis (systematic review) has been conducted.

Does fruit or vegetables intake reduce inflammation and improve immune function?

Study design:
This review article included 71 clinical trials and 12 were observational studies (n = 10 cross-sectional studies and n = 2 cohort studies).

Results and conclusions:
The investigators found among observational studies (n = 10 studies) an inverse association between intakes of fruit or vegetables and inflammatory biomarkers.

The investigators found the majority of the intervention studies (n = 48 studies) reported beneficial effects of fruit or vegetable intake on ≥1 biomarker of systemic or airway inflammation.

The investigators found a meta-analysis of included studies showed that fruit or vegetable intake significantly decreased circulating levels of C-reactive protein and tumor necrosis factor-α [p 0.05] and significantly increased the γδ-T cell population [p 0.05].

The investigators concluded that higher intakes of fruit and vegetables lead to both a reduction in proinflammatory mediators and an enhanced immune cell profile.

Original title:
Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: a systematic literature review and meta-analysis by Hosseini B, Berthon BS, […], Wood LG.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29931038

Additional information of El Mondo:
Find more information/studies on fruit and vegetables and chronic disease right here.

The level of C-reactive protein (CRP), which can be measured in your blood, increases when there's inflammation in your body.

Tumour necrosis factor-alpha (TNF-alpha) is recognized as an important mediator in many cytokine-dependent inflammatory events.

 

Objectives:
Despite the World Health Organization recommendation of exclusive breastfeeding (EBF) for the first six months of life, the rate remains low both in developed and developing countries. In Ethiopia, findings regarding the prevalence of exclusive breastfeeding have been highly variable. Antenatal care and institutional delivery are the most important factors contributing to the practice of exclusive breastfeeding. However, their effect has not been investigated in Ethiopia. Therefore, this review article has been conducted.

Do antenatal care and institutional delivery increase exclusive breastfeeding?

Study design:
This review article included 32 studies (published between 2007 to 2017) with a total of 23,543 breastfeeding women. 29 (71.8%) of the studies are cross-sectional study design. The sample size of the studies ranged from 119 to 5, 227.

Results and conclusions:
The investigators found the result of 32 included studies indicated that the pooled prevalence of exclusive breastfeeding in Ethiopia was 59.3% [95% CI = 53.8 to 64.8%].

The investigators found subgroup analysis indicated that the highest prevalence was observed in Afar region (65.6%), followed by SNNP (63.8%) and then by Oromia (61.8%).

The investigators found mothers who attended antenatal visits were 2.1 times more likely to practice exclusive breastfeeding compared to their counterparts [OR = 2.1, 95% CI = 1.5 to 2.8).

The investigators found, moreover, mothers who gave birth at a health institution were 2.2 times more likely to practice exclusive breastfeeding compared to mothers who gave birth at home [OR = 2.2, 95% CI = 1.3 to 3.5].

The investigators concluded exclusive breastfeeding in Ethiopia is significantly lower than the global recommendations. Mothers who attended antenatal visits and who gave birth at health institutions have better exclusive breastfeeding practices. Based on these findings, it is strongly recommended that the utilization of antenatal care and institutional delivery should be improved through health extension workers.

Original title:
Exclusive breastfeeding practice in Ethiopia and its association with antenatal care and institutional delivery: a systematic review and meta-analysis by Alebel A, Tesma C, […], Kibret GD.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048887/

Additional information of El Mondo:
Find more information/studies on food fortification/malnutrition and breastfeeding right here.

Objectives:
Whether a vegetarian diet is appropriate for pregnancy remains unclear. Therefore, this review article has been conducted.

What is the association between vegetarian diet during pregnancy and various maternal-fetal outcomes?

Study design:
This review article included 19 observational studies.

Results and conclusions:
The investigators found in pooled analysis no association between vegetarian pregnancy and low birth weight (LBW) [RR = 1.27, 95% CI = 0.98-1.65, p = 0.07, I2 = 0%].

The investigators found, however, in subgroup analysis that Asian (India/Nepal) vegetarian mothers exhibited a significantly increased risk of 33% to deliver a baby with low birth weight [RR = 1.33, 95% CI = 1.01-1.76, p = 0.04, I2 = 0%]. But, the WMD of neonatal birth weight in 5 studies suggested no difference between vegetarians and omnivores.

Given the high heterogeneity of the included studies, lack of high-quality evidence and limited studies included for each category, the investigators failed to reach conclusive results regarding the risks of hypospadias, intrauterine growth retardation, maternal anemia and gestational diabetes mellitus.

The investigators concluded that Asian vegetarian mothers have an increased risk to deliver babies with low birth weight than those of omnivores. Large-scale prospective studies focusing on pre- and/or early gestational nutrition will help clarify the correlation between vegetarian diet and various pregnancy outcomes.

Original title:
Is a vegetarian diet safe to follow during pregnancy? A systematic review and meta-analysis of observational studies by Tan C, Zhao Y and Wang S.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29621406

Additional information of El Mondo:
Find more information/studies on veganism and pregnancy right here.

 

Objectives:
Although glucosamine and chondroitin sulfate have showed beneficial effects on joint tissues in osteoarthritis (OA), their therapeutic use in the clinical setting is still debatable. Therefore, this meta-analysis (systematic review) has been conducted.

Do glucosamine and chondroitin sulfate supplements relieve pain of knee osteoarthritis?

Study design:
This review article included RCTs.

The pain of knee osteoarthritis was measured using the Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) and/or the Visual Analog Scale (VAS).

Results and conclusions:
The investigators found that glucosamine supplements significantly reduced pain of knee osteoarthritis (expressed as Visual Analog Scale (VAS) [WMD = - 7.41 mm, 95% CI = - 14.31 to - 0.51, p = 0.04].
Significant means that there is an association with a 95% confidence.

The investigators found that chondroitin supplements significantly reduced pain of knee osteoarthritis (expressed as Visual Analog Scale (VAS) [WMD = - 8.35 mm, 95% CI = - 11.84 to - 4.85, p  0.00001].
Significant because the found p-value of 0.00001 is less than 0.05.

The investigators found that the combination of glucosamine and chondroitin supplements non-significantly reduced pain of knee osteoarthritis (expressed as Visual Analog Scale (VAS) [WMD = - 0.28 mm, 95% CI = - 8.87 to 8.32, p = 0.95].
Non-significantly because the found p-value of 0.95 is greater than 0.05.

The investigators found that none of the glucosamine, chondroitin supplements or their combination had a significant positive effect on the total WOMAC index and its subscores.

The investigators concluded that oral supplementation with glucosamine or chondroitin sulfate reduces pain in knee osteoarthritis. However, there is no additional effect using both therapeutic agents in combination for the management of symptomatic knee osteoarthritis.

Original title:
Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials by Simental-Mendía M, Sánchez-García A, […], Simental-Mendía LE.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29947998

Additional information of El Mondo:
Find more information/studies on chronic disease right here.

 

Objectives:
In the past, some observational studies have been carried out on the relationship between milk and dairy intake and risk of acne occurrence. However, their results were conflicting. Therefore, this meta-analysis (systematic review) has been conducted.

Does milk and dairy intake increase risk of acne?

Study design:
This review article included observational studies.

Results and conclusions:
The investigators found for highest compared with lowest category of dairy intake a significantly increased risk of 161% for acne [OR = 2.61, 95% CI = 1.20 to 5.67].

Significant means that there is an association with a 95% confidence.

The investigators found for highest compared with lowest category of total milk intake a significantly increased risk of 48% for acne [OR = 1.48, 95% CI = 1.31 to 1.66].
Significantly means it can be said with a 95% confidence that a high total milk intake really increased the risk of getting acne with 48%. 

The investigators found for highest compared with lowest category of low-fat milk intake a significantly increased risk of 25% for acne [OR = 1.25, 95% CI = 1.10 to 1.43].
Significant because OR of 1 was not found in the 95% CI of 1.10 to 1.43. RR of 1 means no risk/association.

The investigators found for highest compared with lowest category of skim milk intake a significantly increased risk of 82% for acne [OR = 1.82, 95% CI = 1.34 to 2.47].

The investigators found results of dose-response analysis revealed a significant linear relationship between dairy, whole milk and skim milk and risk of acne and a nonlinear association between dairy, milk, low-fat milk and skim milk intake and acne.

The investigators concluded there is a positive relationship between dairy, total milk, whole milk, low-fat and skim milk consumption and acne occurrence. In contrary, there is no significant association between yogurt/cheese and acne development.

Original title:
Dairy intake and acne development: A meta-analysis of observational studies by Aghasi M, Golzarand M, […], Taheri F.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29778512

Additional information of El Mondo:
Find more information/studies on dairy products and chronic disease right here.
 

Objectives:
The evidence is mixed on the use of long chain omega 3 fatty acids in the prevention and management of childhood asthma. Therefore, this meta-analysis (systematic review) has been conducted.

Does fish consumption reduce risk of childhood asthma?

Study design:
This review article included 23 observational studies on fish intake in association with childhood asthma.

Results and conclusions:
The investigators found in 15/23 studies early introduction of fish (6-9 months) and regular consumption (at least once a week) improved asthma symptoms and reduced risk in children 0-14 years as compared to no fish consumption; 6/23 showed no effect and 2/23 studies suggested adverse effects.

The investigators found a significantly reduced risk of 25% [OR = 0.75, 95% CI = 0.60-0.95] for all fish intake on current asthma in children up to 4.5 years old. 

The investigators found a significantly reduced risk of 38% [OR = 0.62, 95% CI = 0.48-0.80] for all fish intake on current wheeze in children up to 4.5 years old.

The investigators found as compared to no fish intake, a significantly reduced risk of 65% [OR = 0.35, 95% CI = 0.18-0.67] for fatty fish intake on asthma in children 8-14 years old. 

The investigators concluded that introduction of fish early in life (6-9 months) and regular consumption of all fish (at least once a week) reduces asthma and wheeze in children up to 4.5 years old, while fatty fish intake has beneficial effects in older children (8-14 years). Future well-designed clinical trials are recommended to confirm the promising findings documented in this literature analysis.

Original title:
The role of fish intake on asthma in children: A meta-analysis of observational studies by Papamichael MM, Shrestha SK, [...], Erbas B.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29524247

Additional information of El Mondo:
Find more information/studies on chronic diseases and fish consumption right here.

Objectives:
The efficacy of myo-inositol supplementation to prevent gestational diabetes onset remains controversial. Therefore, this meta-analysis (systematic review) has been conducted.

Does myo-inositol supplementation reduce risk of gestational diabetes in pregnant women?

Study design:
This review article included 5 RCTs.

Results and conclusions:
The investigators found compared with control group in pregnant women, myo-inositol supplementation significantly reduced risk of gestational diabetes with 57% [risk ratio = 0.43, 95% CI = 0.21-0.89, p = 0.02].

The investigators found compared with control group in pregnant women, myo-inositol supplementation significantly reduced risk of preterm delivery with 64% [risk ratio = 0.36, 95% CI = 0.17-0.73, p = 0.005].

The investigators found compared with control group in pregnant women, no association between myo-inositol supplementation and 2-h glucose oral glucose tolerance test (OGTT) [mean difference = -6.90, 95% CI = -15.07 to 1.27, p = 0.10].

The investigators found compared with control group in pregnant women, no association between myo-inositol supplementation and gestational age at birth [MD = 0.74, 95% CI = -1.06 to 2.54, p = 0.42].

The investigators found compared with control group in pregnant women, no association between myo-inositol supplementation and birth weight [MD = -5.50, 95% CI = -116.99 to 105.99, p = 0.92].

The investigators found compared with control group in pregnant women, no association between myo-inositol supplementation and macrosomia (a newborn with an excessive birth weight (≥4 kg)) [RR = 0.65, 95% CI = 0.20-2.11, p = 0.47].

The investigators concluded that myo-inositol supplementation reduces the incidence of gestational diabetes and preterm delivery in pregnant women.

Original title:
The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials by Zhang H, Lv Y, […], Guo W.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29343138

Additional information of El Mondo:
Find more information/studies on inositol and pregnancy right here.

A review article (a collection of scientific studies on a specific topic) of randomized, placebo-controlled double blind clinical trials (RCTs) will answer the following question:
"Do taking dietary supplements make sense?" Yes for a positive conclusion and no for a negative conclusion.

Objectives:
Anemia is a major public health and nutritional problem in the world. Studies have reported the relationship between anemia during pregnancy and small for gestational age (SGA). Therefore, this meta-analysis (systematic review) has been conducted.

Does maternal anemia during pregnancy increase risk of SGA?

Study design:
This review article included 10 studies with a total of 620,080 pregnant women.

Results and conclusions:
The investigators found the overall relationship between maternal anemia during pregnancy and SGA was not significant [RR = 1.11, 95% CI = 0.99-1.24, p = 0.074].
Not significant means that there is no association with a 95% confidence.

The investigators found, however, a significantly increased risk of 11% [RR = 1.11, 95% CI = 1.00-1.22, p = 0.044] of SGA for materal anemia during first trimester. But this relationship was not significant in the second trimester [RR = 1.11, 95% CI = 0.85-1.18, p = 0.91].

The investigators concluded maternal anemia in the first trimester of pregnancy increases risk of small for gestational age (SGA).

Original title:
Maternal anemia during pregnancy and small for gestational age: a systematic review and meta-analysis by Badfar G, Shohani M, […], Azami M.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/29183181

Additional information of El Mondo:
Find more information/studies on anemia and pregnancy right here.
 

Objectives:
Zinc is an essential trace element for living organisms and their biological processes. Zinc plays a key role in more than 300 enzymes and it is involved in cell communication, proliferation, differentiation and survival. Zinc also plays a role in regulating the immune system with implications in pathologies where zinc deficiency and inflammation are observed. Therefore, this meta-analysis (systematic review) has been conducted.

Do zinc deficiency increase risk of autoimmune disorders?

Study design:
This review article included 62 case-control studies.

The manner of collecting and investigating zinc samples was very heterogeneous.

Results and conclusions:
The investigators found in fixed model that serum zinc concentration of autoimmune disease patients was significantly lower than in controls [mean effect = -1.19, 95% CI = -1.26 to -1.11].

The investigators found in fixed model that plasma zinc concentration of autoimmune disease patients was significantly lower than in controls [mean effect = -3.97, 95% CI = -4.08 to -3.87].

The investigators concluded that a deficiency of zinc in serum and plasma increases risk of autoimmune disorders in humans.

Original title:
Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis by Sanna A, Firinu D, […], Valera P.

Link:
http://www.mdpi.com/2072-6643/10/1/68/htm

Additional information of El Mondo:
Find here more information/studies about zinc and chronic diseases.

An autoimmune disease is a condition in which your immune system mistakenly attacks your body. These are the most common autoimmune diseases:  

1. Addison’s disease: Caused by an adrenal hormone insufficiency. Addison’s disease can lead to muscle weakness and fatigue, nausea, weight loss, irritability, low blood pressure, low blood sugar and depression.
2. Celiac disease (gluten allergy): Celiac disease is a reaction to gluten (found in barley, rye and wheat) that causes damage to the lining of the small intestine.
3. Graves’ disease: Caused by extremely overactive thyroid gland. People who have Graves’ disease may have difficulty sleeping, bulging of the eyes, irritability, brittle hair, unexplained weight loss, sensitivity to heat, muscle weakness, light menstrual periods and shakiness of the hands. On the other hand, some people with Graves’ disease may experience no symptoms at all.
4. Hashimoto’s disease: Caused by inflammation of the thyroid gland. Although sometimes no symptoms occur, Hashimoto’s thyroiditis often results in a goiter (enlargement of the thyroid gland, which may be visible as a bulge in the neck), weight gain, fatigue, muscle weakness, depression, cold sensitivity, dry hair and skin, and constipation.
5. Inflammatory bowel disease: This disease refers to a group of inflammatory diseases of the colon and small intestine.
6. Multiple Sclerosis or MS: This disease affects the brain and spinal cord. People who have MS may experience weakness, trouble with balance and coordination, problems speaking and walking, tremors, paralysis and numbness in the extremities.
7. Psoriasis: This is a skin condition that causes redness and irritation as well as thick, flaky, silver-white patches.
8. Pernicious anemia: Caused by the inability to absorb vitamin B12 leading to a decrease in red blood cells.
9. Reactive arthritis: Caused by inflammation of joints, the urethra and eyes.
10. Raynaud’s phenomenon: People with Raynaud’s have a problem with blood flow, resulting in numbness, tingling of the fingers, discoloration, toes and tip of the nose with exposure to cold temperatures.
11. Rheumatoid arthritis: In rheumatoid arthritis, autoimmunity causes the immune system to attack tissues in the joints. It typically affects the small joints in your hands and feet causing painful swelling, stiffness and loss of movement in the joints that can eventually result in bone erosion and joint deformity.
12. Scleroderma: Scleroderma is a connective tissue disease that causes changes in skin, muscles, blood vessels and internal organs.
13. Sjögren’s syndrome: Caused by destruction of the glands that produce tears and saliva causing dry eyes and mouth.
14. Systemic lupus erythematosus: In lupus, antibodies made by the immune system attack the body. Systemic lupus erythematosus can affect skin, kidneys, joints and brain.
15. Type 1 diabetes: In type 1 diabetes, the immune system attacks cells in the pancreas that produce insulin. When your insulin levels are insufficient, your body cannot control your blood glucose level, which can lead to a number of problems, including kidney failure, stroke, vision loss, circulation problems and heart disease.